varenicline nasal spray Tyrvaya
Selected indexed studies
- Varenicline Solution Nasal Spray: A Review in Dry Eye Disease. (Drugs, 2022) [PMID:36197638]
- Varenicline nasal spray (Tyrvaya) for dry eye disease. (Med Lett Drugs Ther, 2021) [PMID:35100236]
- Varenicline. (, 2006) [PMID:30000748]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Varenicline Solution Nasal Spray: A Review in Dry Eye Disease. (2022) pubmed
- Varenicline nasal spray (Tyrvaya) for dry eye disease. (2021) pubmed
- The efficacy and safety of varenicline nasal spray for the management of dry eye signs: a systematic review and meta-analysis. (2023) pubmed
- Varenicline Solution Nasal Spray for the Treatment of Dry Eye Disease Following LASIK. (2024) pubmed
- Efficacy of bilateral OC-01 (varenicline solution) nasal spray in alleviating signs and symptoms of dry eye disease: A systematic review. (2024) pubmed
- Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trial. (2024) pubmed
- Topical pharmacologic treatments for dry eye disease: A systematic review. (2025) pubmed
- Quintessence of currently approved and upcoming treatments for dry eye disease. (2025) pubmed
- Varenicline. (2006) pubmed
- Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease. (2023) pubmed